Cochrane systematic review of directly observed therapy for treating tuberculosis: Good analysis of the wrong outcome

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 2, 2007, Pages 120-121

  Rusen, I D ^a   Aït Khaled, Nadia ^a   Alarcón, Edith ^a   Billo, Nils ^a   Bissell, Karen ^a   Boillot, François ^a   Caminero, José ^a   Chiang, Chen Yuan ^a   Clevenbergh, Philippe ^a   Dhliwayo, Panganai ^a   Dlodlo, Riitta ^a   Enarson, Donald A ^a   Ferroussier, Odile ^a   Fujiwara, Paula I ^a   Heldal, Einar ^a   Hinderaker, Sven Gudmund ^a   Sang, Jae Kim ^a   Lienhardt, Christian ^a   Rieder, Hans L ^a   Trébucq, Arnaud ^a   Van Deun, Armand ^a   Wilson, Nevin ^a   more..

^a INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

ANTIBIOTIC RESISTANCE; COCHRANE LIBRARY; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HUMAN; MEDICAL PRACTICE; NOTE; OUTCOME ASSESSMENT; PATIENT EDUCATION; PATIENT MONITORING; PATIENT SATISFACTION; PRIORITY JOURNAL; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DIRECTLY OBSERVED THERAPY; DRUG RESISTANCE, MICROBIAL; HUMANS; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; TUBERCULOSIS, PULMONARY;

EID: 33846857737     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (11)

1. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. [Review]. Cochrane Database Syst Rev 2006; (2): CD003343.
2. Lienhardt C, Ogden J A. Tuberculosis control in resource-poor countries: have we reached the limits of the universal paradigm? Trop Med Intern Health 2004; 9: 833-841.
3. Enarson D A, Rieder H L, Arnadottir T, Trébucq A. Management of tuberculosis. A guide for low income countries. 5th ed. Paris, France: International Union Against Tuberculosis and Lung Disease, 2000.
4. Rieder H L. Interventions for tuberculosis control and elimination. Paris, France: International Union Against Tuberculosis and Lung Disease, 2002.
5. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. 3rd ed. WHO/CDS/TB/2003. 313:1-108. Geneva, Switzerland: WHO, 2003.
6. Toman K. Toman's tuberculosis. Case detection, treatment, and monitoring. Questions and answers. Frieden T R, ed. Geneva, Switzerland: World Health Organization, 2004.
7. World Health Organization. What is DOTS? A guide to understanding the WHO-recommended TB control strategy known as DOTS. WHO/CDS/CPC/TB/99.270:1-30. Geneva, Switzerland: WHO, 1999.
8. Frieden T, Sbarbaro J A. The slippery slope to sloppy DOTS. [Editorial]. Int J Tuberc Lung Dis 2002; 6: 271-272.
9. Enarson D A. Principles of IUATLD Collaborative Tuberculosis Programmes. Bull Int Union Tuberc Lung Dis 1991; 66(4): 195-200.
10. Garner P, Volmink J. Families help cure tuberculosis. [Comment]. Lancet 2006; 367: 878-879.
11. Weis S E, Slocum P C, Biais F X, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med 1994; 330: 1179-1184.